Clinical Trials in Tennessee

Showing 17781-17800 of 20,239 trials

A Study of HGS1029 (AEG40826-2HCl) in Subjects With Advanced Solid Tumors

NCT00708006

The purpose of this study is to evaluate the safety and tolerability of HGS1029 in subjects with advanced solid tumors and to determine a phase 2 dose.

Advanced Solid Tumors

Human Genome Sciences Inc.66 participantsStarted May 2008

Stanford, California, United States • Aurora, Colorado, United States • Nashville, Tennessee, United States

COMPLETEDPhase 329 miles

Cytarabine With or Without VNP40101M in Treating Patients With Relapsed Acute Myeloid Leukemia

NCT00112554

RATIONALE: Drugs used in chemotherapy, such as cytarabine and VNP40101M, work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more cancer cells. PURPOSE: This randomized phase III trial is studying cytarabine and VNP40101M to see how well they work compared to cytarabine alone in treating patients with relapsed acute myeloid leukemia.

Leukemia

Vion Pharmaceuticals420 participantsStarted Mar 2005

Los Angeles, California, United States • Los Angeles, California, United States • Orange, California, United States +59 more locations

A Study of HGS1029 (AEG40826-2HCl) in Subjects With Advanced Solid Tumors

Cytarabine With or Without VNP40101M in Treating Patients With Relapsed Acute Myeloid Leukemia

Find Trials by Condition in Tennessee

VNP40101M in Treating Patients With Relapsed or Refractory Locally Advanced or Metastatic Small Cell Lung Cancer

3-AP and Gemcitabine in Treating Patients With Metastatic Non-Small Cell Lung Cancer

Phase 2b Study of Cetuximab With Platinum-Based Chemo as First Line Treatment of Recurrent or Advanced NSCLC

A Study Of AG-013736 (Axitinib) Or Bevacizumab (Avastin) In Combination With Paclitaxel And Carboplatin In Patients With Advanced Lung Cancer.

Interleukin-2 in Treating Patients With Stage III or Stage IV Kidney Cancer That Has Been Removed With Surgery

Monoclonal Antibody Therapy in Treating Patients With Residual Disease From Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer Following Surgery and Chemotherapy

A Long-Term Study of Aripiprazole in Patients With Major Depressive Disorder

S9624 Ifosfamide in Treating Patients With Meningeal Tumors

Carmustine in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme

Biological Therapy in Previously Treated Patients With Non-small Cell Lung Cancer

Monoclonal Antibody Therapy in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer

T4N5 Liposome Lotion Compared With Placebo Lotion for Preventing Actinic Keratoses in Patients With Xeroderma Pigmentosum

Investigation of Efficacy, Safety and Tolerability of Once and Twice Daily Doses of AZD1981 in Asthmatic Patients

ONCONASE Plus Doxorubicin Versus Doxorubicin Alone For Patients With Malignant Pleural or Peritoneal Mesothelioma Who Have Had No More Than One Prior Chemotherapy Regimen

Study of Aripiprazole in Patients With Acute Bipolar Mania

A Study to Compare Three Different Formulations of Tenofovir 1% Gel When Administered Rectally

3-AP in Treating Patients With Advanced Prostate Cancer

Radiation Therapy in Treating Patients With Stage I or Stage II Prostate Cancer